Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Merriline Satyamitra

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Radiation Research|December 4, 2003
In vivo postirradiation protection by a vitamin E analog, alpha-TMGMerriline Satyamitra, P Uma Devi, Hironobu Murase, et al.
Radiation Research|June 18, 2021
Challenges and Strategies in the Development of Radiation Biodosimetry Tests for Patient ManagementMerriline Satyamitra, Francisca E Reyes Turcu, Norberto Pantoja-Galicia, et al.
Disaster Medicine and Public Health Preparedness|October 7, 2024
Success! - CORRIGENDUMJames J James, Merriline Satyamitra, Tom Hu, et al.
International Journal of Toxicology|April 6, 2013
Preliminary nonclinical toxicity, pharmacokinetics, and pharmacodynamics of ALXN4100TPO, a thrombopoietin receptor agonist, in CD2F1 miceMerriline Satyamitra, Eric Lombardini, Tao Peng, et al.
Radiation Research|April 1, 2017
Impact of Abbreviated Filgrastim Schedule on Survival and Hematopoietic Recovery after Irradiation in Four Mouse Strains with Different RadiosensitivityMerriline Satyamitra, Vidya P Kumar, Shukla Biswas, et al.
Scientific Reports|February 6, 2020
CDX-301: a novel medical countermeasure for hematopoietic acute radiation syndrome in miceMerriline Satyamitra, Lynnette Cary, Dylan Dunn, et al.
Disaster Medicine and Public Health Preparedness|April 27, 2026
The Importance of Medical Preparedness for Radiation EmergenciesAndrea DiCarlo, Merriline Satyamitra, Nelson Chao, et al.
Molecular Cancer Therapeutics|July 5, 2006
Inhibition of Akt by the alkylphospholipid perifosine does not enhance the radiosensitivity of human glioma cellsLorena de la Peña, William E Burgan, Donna J Carter, et al.
Radiation Research|April 12, 2011
A TPO receptor agonist, ALXN4100TPO, mitigates radiation-induced lethality and stimulates hematopoiesis in CD2F1 miceMerriline Satyamitra, Eric Lombardini, John Graves, et al.
International Journal of Radiation Biology|September 11, 2023
Minimum reporting standards should be expected for preclinical radiobiology irradiators and dosimetry in the published literatureFrançois Trompier, Larry A DeWerd, Yannick Poirier, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Radiation Research|December 4, 2003
In vivo postirradiation protection by a vitamin E analog, alpha-TMGMerriline Satyamitra, P Uma Devi, Hironobu Murase, et al.
Radiation Research|June 18, 2021
Challenges and Strategies in the Development of Radiation Biodosimetry Tests for Patient ManagementMerriline Satyamitra, Francisca E Reyes Turcu, Norberto Pantoja-Galicia, et al.
Disaster Medicine and Public Health Preparedness|October 7, 2024
Success! - CORRIGENDUMJames J James, Merriline Satyamitra, Tom Hu, et al.
International Journal of Toxicology|April 6, 2013
Preliminary nonclinical toxicity, pharmacokinetics, and pharmacodynamics of ALXN4100TPO, a thrombopoietin receptor agonist, in CD2F1 miceMerriline Satyamitra, Eric Lombardini, Tao Peng, et al.
Radiation Research|April 1, 2017
Impact of Abbreviated Filgrastim Schedule on Survival and Hematopoietic Recovery after Irradiation in Four Mouse Strains with Different RadiosensitivityMerriline Satyamitra, Vidya P Kumar, Shukla Biswas, et al.
Scientific Reports|February 6, 2020
CDX-301: a novel medical countermeasure for hematopoietic acute radiation syndrome in miceMerriline Satyamitra, Lynnette Cary, Dylan Dunn, et al.
Disaster Medicine and Public Health Preparedness|April 27, 2026
The Importance of Medical Preparedness for Radiation EmergenciesAndrea DiCarlo, Merriline Satyamitra, Nelson Chao, et al.
Molecular Cancer Therapeutics|July 5, 2006
Inhibition of Akt by the alkylphospholipid perifosine does not enhance the radiosensitivity of human glioma cellsLorena de la Peña, William E Burgan, Donna J Carter, et al.
Radiation Research|April 12, 2011
A TPO receptor agonist, ALXN4100TPO, mitigates radiation-induced lethality and stimulates hematopoiesis in CD2F1 miceMerriline Satyamitra, Eric Lombardini, John Graves, et al.
International Journal of Radiation Biology|September 11, 2023
Minimum reporting standards should be expected for preclinical radiobiology irradiators and dosimetry in the published literatureFrançois Trompier, Larry A DeWerd, Yannick Poirier, et al.
Pageof 2